Skip to content

Cureskin Raises $20M to Enhance AI-Powered Dermatology Solutions

Cureskin secures $20 million in Series B funding to expand its AI-driven dermatology platform, aiming to offer personalized skin and hair care solutions across India. With this investment, Cureskin is set to accelerate growth and enhance its AI capabilities.

Cureskin, an innovative AI-driven dermatology platform, has successfully secured $20 million in a Series B funding round. The investment was led by HealthQuad, with participation from existing investors including JSW Ventures, Khosla Ventures, and Sharrp Ventures. This significant infusion of capital marks a pivotal moment for the Bengaluru-based startup, founded in 2017 by Guna Kakulapati, Ramakrishna Rajanna, and Charu Sharma.

Utilization of Funds for Growth and Expansion

The funds from this latest round will be strategically used to bolster Cureskin's AI capabilities, enhance its product offerings, and accelerate the company's growth trajectory. Cureskin aims to leverage this investment to scale up its operations significantly and extend its reach across India, promising to deliver personalized skin and hair care solutions to a broader audience.

Innovation at the Core of Cureskin

At its heart, Cureskin utilizes advanced AI technology within its app to provide users with customized skin and hair care regimens, prescribed by dermatologists. The platform stands out for its commitment to ongoing support, offering guidance and follow-up consultations with dermatologists to ensure the effectiveness of its solutions.

A Robust AI Foundation

Cureskin's AI system is notably sophisticated, capable of analyzing over 10 million skin pixels from user photos. This analysis identifies more than 2,000 facial attributes, allowing for the accurate detection of various skin conditions. With a database trained on more than 50 million images, the platform can categorize consumers into over 65,000 unique profiles, tailoring its offerings to meet specific user needs effectively.

Impact and Reach

To date, Cureskin has served over 1.5 million customers, with a significant 80% hailing from Tier-II and Tier-III regions. This wide-reaching impact underscores the startup's commitment to making dermatological care accessible to a diverse demographic across the country.

Resilience in the Face of Funding Winter

The successful fundraising comes during a challenging period for the Indian startup ecosystem, characterized by a so-called "funding winter." Despite this, healthtech startups like Cureskin are witnessing a resurgence of investor interest, highlighting the sector's potential for sustained growth and innovation.

The healthtech industry in India is on a trajectory of rapid expansion, with projections indicating a market size of $21.3 billion by 2025. Cureskin's recent funding achievement positions it as a key player in this burgeoning space, poised to make significant contributions to the evolution of AI-powered dermatological care.